Phase III Study of KX-826 With Adult Male Patients With AGA

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

740

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Androgenetic Alopecia
Interventions
DRUG

KX-826-(5%) BID

Dosage and administration: Topical application, 7 sprays (approximately 1 ml)/time, in the target area of the scalp, starting from the center of the affected area and massaging with hands until absorption. It should be used when the hair and scalp are completely dry. Wash hands after use. The randomized active drug would be administered to the scalp once in the morning and once in the evening.

OTHER

Placebo

Dosage and administration: Topical application, 7 sprays (approximately 1 ml)/time, in the target area of the scalp, starting from the center of the affected area and massaging with hands until absorption. It should be used when the hair and scalp are completely dry. Wash hands after use. The randomized matching placebo would be administered to the scalp once in the morning and once in the evening.

Trial Locations (26)

Unknown

The Second Hospital Of Anhui Medical University, Hefei

Beijing Friendship Hospital,Capital Medical University, Beijing

Beijing Tongren Hospital,Cmu, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

China-Japan Friendship Hospital, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Dermatology Hospital of Southern Medical University, Guangzhou

Guangdong Provincial People's Hospital, Guangzhou

Shenzhen People's Hospital, Shenzhen

Sir Run Run Shaw Hospital,ZheJiang University School Of Medicine, Zhejiang

The First Hospital Of Hebei Medical University, Shijiazhuang

The First Affiliated Hospital Of Zhengzhou University, Zhengzhou

Wuhan Hospital Of Traditional Chinese And Western Medicine, Wuhan

The Second Xiangya Hospital Of Central South University, Changsha

Xiangya Hospital Central South University, Changsha

Affiliated Hospital of Jiangsu University, Zhenjiang

The First Hospital Of China Medical University, Shenyang

Huashan Hospital, Shanghai

Shanghai Dermatology Hospital, Shanghai

West China Hospital Sichuan University, Chengdou

Tianjin Academy Of Traditional Chinese Medicine Affiliated Hospital, Tianjin

Tianjin Medical University General Hospital, Tianjin

Affiliated Hangzhou First People's Hospital,Zhejiang University School Of Medicine, Hangzhou

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Suzhou Koshine Biomedica, Inc.

INDUSTRY

lead

Suzhou Kintor Pharmaceutical Inc,

INDUSTRY